Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data from the Systolic Blood Pressure Intervention Trial (SPRINT)
Journal article published in 2022 by
J. B. Cohen 
,
Z. A. Marcum,
C. Zhang,
J. B. King,
Supiano,
J. A. Sonnen,
W. S. Weintraub,
D. Scharfstein,
J. Williamson,
N. M. Pajewski,
T. H. Greene,
Jennifer S. Herrick ,
C. G. Derington,
A. K. Cheung,
N. Bryan
and other authors.
,
Z. A. Marcum,
C. Zhang,
J. B. King,
Supiano,
J. A. Sonnen,
W. S. Weintraub,
D. Scharfstein,
J. Williamson,
N. M. Pajewski,
T. H. Greene,
Jennifer S. Herrick ,
C. G. Derington,
A. K. Cheung,
N. Bryan
and other authors.
